Table 3.
Drug resistance to PIs in the patients
ATV | DRV | FPV | IDV | LPV/r | NFV | SQV | TPV | |
---|---|---|---|---|---|---|---|---|
N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
P | 14 (1.50) | 0 | 17 (1.82) | 14 (1.50) | 15 (1.61) | 7 (0.75) | 0 | 11 (1.18) |
L | 0 | 0 | 0 | 1 (0.11) | 0 | 14 (1.50) | 1 (0.11) | 4 (0.43) |
I | 0 | 0 | 0 | 0 | 0 | 2 (0.21) | 0 | 0 |
H | 1 (0.11) | 0 | 0 | 0 | 0 | 1 (0.11) | 0 | 0 |
Drug resistance | 1 (0.11) | 0 | 0 | 1 (0.11) | 0 | 17 (1.82) | 1 (0.11) | 4 (0.43) |
P, potential resistance; L, low resistance; I, intermediate resistance; H, high resistance.
ATV, atazanavir; DRV, darunavir; FPV, fosamprenavir; IDV, indinavir; LPV/r, kaletra; NFV, nelfinavir; SQV, saquinavir; TPV, tipranavir.
Drug resistance=L+I+H.